Anika Therapeutics Non-GAAP EPS of $0.31 beats by $0.29, revenue of $30.6M beats by $1.72M
Source: SeekingAlpha
2026-02-26 07:21:59 ET
More on Anika Therapeutics
- Anika Therapeutics appoints Stephen Griffin as CEO
- Seeking Alpha’s Quant Rating on Anika Therapeutics
- Historical earnings data for Anika Therapeutics
- Financial information for Anika Therapeutics
Read the full article on Seeking Alpha
For further details see:
Anika Therapeutics Non-GAAP EPS of $0.31 beats by $0.29, revenue of $30.6M beats by $1.72M
Anika Therapeutics Inc.
NASDAQ: ANIK
ANIK Trading
0.21% G/L:
$14.46 Last:
91,495 Volume:
$14.36 Open:
ANIK Latest News
February 18, 2026 04:01:00 pm
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
February 12, 2026 04:01:00 pm
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
ANIK Stock Data
$150,557,526
10,879,368
2.15%
33
N/A
Medical Equipment & Supplies
Healthcare
US
Bedford
